HOME JOURNALS CONTACT

Asian Journal of Plant Sciences

Year: 2004 | Volume: 3 | Issue: 1 | Page No.: 82-86
DOI: 10.3923/ajps.2004.82.86
Evaluation of Antibacterial Properties of Iranian Medicinal-Plants against Micrococcus luteus, Serratia marcescens, Klebsiella pneumoniae and Bordetella bronchoseptica
G.H. Shahidi Bonjar

Abstract: From 195 plant samples in 76 families used by Iranian Native People for curing infectious maladies, methanolic extracts of 64 samples in 37 families showed antibacterial activity at least against one bacterial species of Bordetella bronchoseptica, Micrococcus luteus, Klebsiella pneumoniae and Serratia marcescens. High activity belonged to Terminalia chebula, Myrtus communis, Dianthus coryophyllus, Rhus coriaria, Lawsonia inermis and Alpinia officinarum against B. bronchiseptica; T. chebula, M. communis, D. coryophyllus, Glycyrrhiza glabra, Ranunculus asitaticus, R. coriaria, Rheum ribes, Chrozophora verbasafalia, Ephedra intermedia, Cinnamomum zeylanicum and Citrullus colcocynthis against M. luteus; R. ribes, R. coriaria and G. glabra against K. pneumoniae. No plant showed high or medium activity against Serratia marcescens. Umbelliferae with 7, Labiatae with 6 and Compositae with 4, had most number of active samples per plant family. Lowest MIC belonged to T. chebula (ripen seeds) and M. communis (leaves) as 0.93 mg ml-1, against B. bronchiseptica and to T. chebula (unripe seeds) as 0.46 mg ml-1 against M. luteus and to R. ribes and R. coriaria as 1.87 mg ml-1 against K. pneumoniae. Most susceptible bacterium was B. bronchiseptica and most resistant bacterium was S. marcescens. All of the active extracts were well stable at room temperature up to 18 months and did not show any reduction of activity against the sensitive bacterial isolates.

Fulltext PDF Fulltext HTML

How to cite this article
G.H. Shahidi Bonjar , 2004. Evaluation of Antibacterial Properties of Iranian Medicinal-Plants against Micrococcus luteus, Serratia marcescens, Klebsiella pneumoniae and Bordetella bronchoseptica. Asian Journal of Plant Sciences, 3: 82-86.

Keywords: iranian medicinal-plants, Micrococcus luteus, serratia marcescens, klebsilla pneumoniae, Antibacterial and bordetella bronchoseptica

INTRODUCTION

During the last two decades, due to the increasing development of drug resistance in pathogenic microorganisms as well as the appearance of undesirable side effects of certain antibiotics and the emergence of previously uncommon infections[1-8] antimicrobial properties have been reported in a wide range of plant extracts with the goal to discover new chemical classes of antibiotics that could resolve these problems[9-22]. Traditionally, usage of plants in curing illnesses has deep roots in man's history[23]. Ethnopharmacological uses of plants prevail among Iranian Native People (INP). They use plants in treating burns, dermatophytes and infectious diseases. The curative plants vary between these natives in different localities. In order to screen and determine antibacterial effects of these plants, four different bacterial species including a gram positive, Micrococcus luteus and three gram negative bacteria Serratia marcescens, Klebsiella pneumoniae and Bordetella bronchoseptica were used. M. luteus causes minor infections especially in patients with suppressed immune system. S. marcescens is a common opportunistic pathogen causing pneumonia, bacteremia and endocarditis-especially in narcotics addicts and hospitalized patients. K. pneumoniae is present in the respiratory tract of about 5% of normal individuals; it can produce extensive hemorrhagic necrotizing consolidation of the lung. It occasionally produces urinary tract infection and bacteremia with focal lesions in debilitated patients. It also causes hospital-acquired infections. B. bronchoseptica occasionally inhibits the respiratory tracts, in which causes infections as a common opportunistic pathogen. It also infects respiratory tracts of canines, in which it may cause "Kennel cough" and pneumonitis[24]. In a two-year study, 195 species of INP-medicinal plants were tested in an in vitro bioassay method against these bacteria.

MATERIALS AND METHODS

Plant material: One hundred ninety five plant samples belonging to 76 families, being used by INP, were collected from South-East regions of Iran and identified by Mrs. P. Rashid Farrokhi in the Herbarium of Plant Systematic Laboratory of the College of Agricultural Sciences, Bahonar University of Kerman, Iran, where voucher specimens of plants were deposited. Twenty species, used in INP but not grown in Iran, were prepared through the mentioned Herbarium. According to the information gathered about the ethnopharmacological usages, the plant organs used in this study were the same as used by INP.

Preparation of the extracts: The plant parts were dried in shade or an oven at 40°C and powdered with mortar and pestle or by coffee blender. The methanol extracts were prepared by maceration of the plant material with methanol for 3 days at room temperature and this procedure was repeated twice. The respective extracts were filtered and dried under reduced pressure at a temperature below 45°C to yield a dense residue. Sample transferred to glass vials and lyophilized overnight before use.

Preparation of test samples: In the study of the antimicrobial activity, the methanol extracts were diluted in dimethylsulfoxide (DMSO): methanol (1: 1, v/v) solvent. As a precaution not to miss trace amounts of antimicrobials, for preliminary screening, a relatively high concentration of 20 mg ml-1 of each extract was prepared for bioassays.

Test microorganisms: The plant extracts were assayed for antimicrobial activity against five registered bacterial-isolates which were obtained from the Persian Type Culture Collection, Tehran, Iran (PTCC). The bacteria included two Gram-positive bacterial isolates: Micrococcus luteus (PTCC No. 1110) and M. luteus (PTCC No. 1170) and three Gram-negative bacteria: Bordetella bronchiseptica (PTCC No. 1025), Klebsiella pneumoniae (PTCC No. 1053) and Serratia marcescens (ATCC No. 27117). The bacteria were rejuvenated on Mueller-Hinton-Agar medium (MHM, Merk, Germany) and subcultured as needed.

Antimicrobial bioassay: For bioassays, suspension of approximately 1.5x108 bacterial cells ml-1 in sterile normal saline were prepared as described by Forbes et al.[25] and about 1.5 ml of it was uniformly seeded on MHM in 12x1.2 cm glass Petri dishes, left aside for 15 min and excess of suspension was then drained and discarded properly. Wells of 6 mm in diameter and about 2 cm apart were punctured in the culture media using sterile cork borers. Respective concentrations were administered to fullness in each well. Culture plates, were incubated at 37°C for 48 h. Bioactivity was determined by measuring Diameter of inhibition zones (DIZ) in mm. Each experiment was repeated three times and the mean of the diameter of the inhibition zones was calculated. Controls included use of solvent without test compounds, although no antibacterial activity noted in the solvent employed for the test.

Determination of Minimum Inhibitory Concentrations (MIC): To measure the MIC values, concentrations of 15, 7.5, 3.75, 1.87, 0.93 and 0.46 mg ml-1 of the methanolic extracts were prepared in DMSO: methanol (1/1: v/v) solvent and assayed against the bacteria as mentioned earlier. The MIC was defined as the lowest concentration able to inhibit any visible bacterial growth. All data represent average of three replicated experiments.

Determination of Shelf life or Stability of the active extracts: To measure the stability of the active extracts in both soluble and dry states, 20 mg ml-1 of each sample was prepared in DMSO: methanol (1:1, v/v) solvent and 20 mg dry samples placed in small vials. These samples were kept at room temperature and tested for antibacterial activity against the most sensitive bacterium at 14 days intervals up to 18 months.

RESULTS

From 195 plant samples in 76 families used by INP 64 samples in 37 families showed antibacterial activity at least against one of the bacterial species (Table 1). The activities were rated into three classes as: poor (DIZ<12mm), medium (DIZ 12 to <15 mm) and high (DIZ>15 mm or higher). Plants with high activity were as follows: Terminalia chebula, Myrtus communis, Dianthus coryophyllus, Rhus coriaria, Lawsonia inermis and Alpinia officinarum effective against Bordetella bronchiseptica (PTCC No. 1025); T. chebula, M. communis, D. coryophyllus, Glycyrrhiza glabra, Ranunculus asitaticus, R. coriaria, Rheum ribes, Chrozophora verbasafalia, Ephedra intermedia and Cinnamomum zeylanicum against Micrococcus luteus (PTCC No. 1110); Citrullus colcocynthis effective against M. luteus (PTCC No. 1170); and R. ribes, R. coriaria and G. glabra effective against Klebsiella pneumoniae (PTCC No. 1053). No plant showed high or medium activity against Serratia marcescens (ATCC No. 27117), only Petroselinum sativum and Ziziphus spini-christi had poor activity against it. Umbelliferae with seven, Labiatae with six and Compositae with four, had most number of active samples per plant family.

Table 1: Evaluation results against four bacterial species of Micrococcus luteus, Serratia marcescens, Klebsiella pneumoniae and Bordetella bronchoseptica of 195 plant samples in 76 families used by Iranian Native People, from which 64 plant samples in 37 families showed inhibitory effects at least against one bacterial species. Antibacterial activity indicated by Diameter of inhibition zones (DIZ, mm), Minimum Inhibitory Concentration (MIC), plant species, families, used organs and bacterial species are listed. Plants whose DIZ values indicated in bold are rated as high actives, DIZ values underlined are rated as medium actives and DIZ values shown in regular font-style are rated as poor actives against the respective bacteria
DIZ= Diameter of Inhibition Zone (mm) at 20 mg ml-1. MIC= Minimal Inhibitory Concentration (mg ml-1). OT= Organs tested, as FL: Flower, FR: Fruit, LE: Leaves, RH: Rhizome, RO: Roots, SB: Stem Bark, SE: Seeds, SG: Stem Gum, ST: Stem and WP: Whole Plant. a= Bordetella bronchiseptica (PTCC No. 1025), b= Micrococcus luteus (PTCC No. 1110), c= M. luteus (PTCC No. 1170), d= Klebsiella pneumoniae (PTCC No. 1053), e= Serratia marcescens (ATCC No. 27117)

Lowest MIC belonged to T. chebula (ripen seeds) and M. communis (leaves) as 0.93 mg ml-1 against B. bronchiseptica and to T. chebula (unripe seeds) as 0.46 mg ml-1 against M. luteus and to R. ribes and R. coriaria as 1.87 mg ml-1 against K. pneumoniae. Most susceptible bacterium was B. bronchiseptica being sensitive to 52 plant samples and most resistant bacterium was S. marcescens being susceptible only to three samples. All other 131 plant samples which did not show any inhibitory effects are not listed in the table. At 20 mg ml-1 concentration the largest DIZ belonged to M. communis leaves (26 mm) and Terminalia chebula ripen seeds (25 mm). All of the active extracts were well stable at room temperature in both DMSO: methanol (1:1, v/v) solvent and dry state up to 18 months and did not show any reduction of activity against the sensitive bacteria as compared to the starting day.

DISCUSSION

Many published reports show the effectiveness of traditional herbs against microorganisms, as a result, plants are one of the bedrocks for modern medicine to attain new principles[26]. In this regard, plants have given western pharmacopoeia about 7000 different pharmaceutically important compounds and a number of top-selling drugs of modern time, e.g. quinine, artemisinin, taxol, camptothecin, etc.[27].

Acquired resistance to antibiotics in bacteria over 25 years now constitutes a serious threat to public health[8,7]. The phenomenon is further compounded by demographic factors (e.g. population growth and urbanization) which generate fertile conditions for the transmission of infections and new opportunities for inter-species traffic of pathogens to man. Problem of antibiotic resistance in both hospital-acquired (nosocomial) and community- acquired bacterial infections have made many antibiotics virtually obsolete. As the reports show, no antibiotic can last effective too long. To combat the problem of microbial antibiotic resistance, one logical way is providing new agents. It is vital that research strategies be oriented toward discovery and development of antimicrobial agents urgently required in the future.

I suggest the most active extracts presented (Table 1) for evaluation against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) isolates[28, 29] two of the most problematic bacteria.

Smith et al.[30] express that "The emergence of bacterial resistance threatens to return us to the era before the development of antibiotics" and I like to express that "For not loosing the battle in the war against antimicrobial-resistant bacteria, one major way is to extend man's knowledge about the new antimicrobial sources". The results of such studies form the avenue for further investigations to find new drugs for therapeutic usages.

ACKNOWLEDGMENTS

Efforts of Research Affairs Office of Bahonar Univ. of Kerman are appreciated. Helpful work of Mrs. Parvin Rashid Farrokhi and her colleagues on scientific diagnosis of plants is appreciated. The spiritual result of this research is dedicated to the soul of Mr. A. Afzalipour the founder of Universities in Kerman, God bless him.

REFERENCES

  • Piddock, K.J.V. and R. Wise, 1989. Mechanism of resistance to quinolones and clinical perspective. J. Antimicrob. Chemotherap., 23: 475-483.


  • Mulligan, M.E., K.A. Murray-Leisure, B.S. Ribner, H.C. Standiford and J.F. John et al., 1993. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management. Am. J. Med., 94: 313-328.
    CrossRef    PubMed    Direct Link    


  • Davies, J., 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science, 264: 375-382.
    CrossRef    Direct Link    


  • Enne, V.I., D.M. Livermore, P. Stephens and L.M.C. Hall, 2001. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet, 357: 1325-1328.
    CrossRef    Direct Link    


  • Marchese, A. and G.C. Shito, 2001. Resistance patterns of lower respiratory tract pathogens in Europe. Int. J. Antimicrob. Agents, 16: 25-29.
    CrossRef    PubMed    Direct Link    


  • Cohen, R., F. De la Rocque, M. Boucherat, E. Bingen and P. Geslin, 1994. Treatment failure in otitis media: An analysis. J. Chemotherapy, 6: 17-22.


  • Poole, K., 2001. Overcoming antimicrobial resistance by targeting resistance mechanisms. J. Pharm. Pharmacol., 53: 283-294.
    PubMed    Direct Link    


  • Herrera, R.M., M. Perez, D.A. Martin-Herrera, R. Lopez-Garcia and R.M. Rabanal, 1996. Antimicrobial activity of extracts from plants endemic to the Canary Islands. Phytotherap. Res., 10: 364-366.
    Direct Link    


  • De Smet, P.A., 1997. The role of plant-derived drugs and herbal medicines in healthcare. Drugs, 54: 801-840.
    PubMed    


  • Cowan, M.M., 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev., 12: 564-582.
    CrossRef    PubMed    Direct Link    


  • Hernandez-Perez, M., R.M. Rabanal, A. Arias, M.C. De la Torre and B. Rodriguez, 1999. Aethiopinone, an antibacterial and cytotoxic agent from Salvia aethiopis roots. Pharm. Bio., 37: 17-21.


  • Sokmen, A., B.M. Jones and M. Erturk, 1999. The in vitro antibacterial activity of Turkish medicinal plants. J. Ethnopharmacol., 67: 79-86.
    CrossRef    PubMed    Direct Link    


  • Kelmanson, J.E., A.K. Jager and J. van Staden, 2000. Zulu medicinal plants with antibacterial activity. J. Ethnopharmacol., 69: 241-246.
    CrossRef    PubMed    Direct Link    


  • Meng, J.C., Q.X. Zhu and R.X. Tan, 2000. New antimicrobial mono- and sesquiterpenes from Soroseris hookeriana subsp. erysimoides. Planta Med., 66: 541-544.
    CrossRef    PubMed    Direct Link    


  • Ruberto, G., M.T. Baratta, S.G. Deans and H.J.D. Dorman, 2000. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med., 66: 687-693.
    CrossRef    PubMed    Direct Link    


  • Ahmad, I. and A.Z. Beg, 2001. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J. Ethnopharmacol., 74: 113-123.
    CrossRef    Direct Link    


  • Awadh Ali, N.A., W.D. Julich, C. Kusnick and U. Lindequist, 2001. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J. Ethnopharmacol., 74: 173-179.
    CrossRef    PubMed    Direct Link    


  • Ho, K.Y., C.C. Tsai, H.S. Huang, C.P. Chen, T.C. Lin and C.C. Lin, 2001. Antimicrobial activity of tannin components from Vaccinium vitis-idaea L. J. Pharm. Pharmacol., 53: 187-191.
    CrossRef    Direct Link    


  • Mansouri, S., A. Foroumadi, T. Ghanei and A.G. Najar, 2001. Antibacterial activity of the crude extracts and fractionated constituents of Myrtus communis. Pharm. Biol., 39: 399-401.
    Direct Link    


  • Srinivasan, D., S. Nathan, T. Suresh and P.L. Perumalsamy, 2001. Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine. J. Ethnopharmacol., 74: 217-220.
    CrossRef    PubMed    Direct Link    


  • Yoshikazu, S., H. Murata, T. Nakanishi and Y. Inatomi, 2001. Inhibitory effect of plant extracts on production of verotoxin by enterohemorrhagic Escherichia coli O157: H7. J. Health Sci., 47: 473-477.
    Direct Link    


  • Grabley, S. and R. Thiericke, 1999. Drug Discovery from Nature. Spinger, London, pp: 5-7


  • Brooks, G.F., J.S. Butel, L.N. Ornston, E. Jawetz, J.L. Melnick and E.A. Adelberg, 1991. Medical Microbiology. 19th Edn., Appleton and Lange, New York, pp: 245-246


  • Evans, C.E., A. Banso and O.A. Samuel, 2002. Efficacy of some nine medicinal plants against Salmonella typhi. An in vitro study. J. Ethnopharmacol., 80: 21-24.


  • Tshibangu, J.N., K. Chifundera, R. Kaminsky, A.D. Wright and G.M. Konig, 2002. Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity. J. Ethnopharmacol., 80: 25-35.
    CrossRef    Direct Link    


  • Cookson, B.D., 2000. Methicillin-resistant Staphylococcus aureus in the community: New battlefronts, or are the battles lost? Infect. Control Hosp. Epidemiol., 21: 398-403.
    CrossRef    Direct Link    


  • Shopsin, B., B. Mathema, J. Martinez, E. Ha and M.L. Campo et al., 2000. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J. Infect. Dis., 182: 359-362.
    PubMed    Direct Link    


  • Smith, T.L., M.L. Pearson, K.R. Wilcox, C. Cruz and M.V. Lancaster et al., 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med., 340: 493-501.
    Direct Link    


  • WHO., 2001. WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization, Geneva


  • Forbes, B.A., D.F. Sahm, A.S. Weissfeld and E.A. Trevino, 1990. Methods for Testing Antimicrobial Effectiveness. In: Bailey Scott's Diagnostic Microbiology, Baron, E.J., L.R. Peterson and S.M. Finegold (Eds.). Mosby Co., St Louis, Missouri, MI., pp: 171-194

  • © Science Alert. All Rights Reserved